Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 7Phase 2/3 4Phase 1/2 3Phase 1 2

Status

Recruiting 4Not yet recruiting 4Completed 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Leukemia, Myeloid, Acute 4

Interventions

Cisplatin 10Gemcitabine 7Fluorouracil 7Carboplatin 7Capecitabine 7venetoclax 6Oxaliplatin 5Cyclophosphamide 4Azacitidine 4sintilimab 3Radiotherapy 3Neoadjuvant Therapy 3Dexamethasone 3Bevacizumab 3130-nm albumin-bound paclitaxel 3trametinib 2regorafenib 2pembrolizumab 2nimotuzumab 2fludarabine 2disitamab vedotin 2daratumumab 2dabrafenib 2camrelizumab 2blinatumomab 2apatinib 2Trastuzumab 2Temozolomide 2Radiotherapy, Intensity-Modulated 2Radiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Not yet recruiting × Azacitidine × Clear all
NCT07623187 2026-06-03

EVICTION 3

Ipsen

Phase 2/3 Not yet recruiting
450 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07581002 2026-05-12

REVIVAL

AbbVie

Phase 2/3 Not yet recruiting
660 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07255872 2026-03-05

A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2/3 Not yet recruiting
216 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07425808 2026-02-23

FIT-AML

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Not yet recruiting
230 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡